免缝合与快速释放主动脉瓣置换国际注册研究(SURD-IR):3343例患者早期结果
SURD-IR注册研究由18个中心组成的国际瓣膜外科研究组建立,收集2007至2017年3343例免缝合与快速释放主动脉瓣置换(SURD-AVR)患者数据,平均年龄76.8±6.7岁,平均logistic EuroSCORE 11.3±9.7%。总体院内死亡率为2.1%,孤立SURD-AVR为1.4%,合并手术为3.5%(P<0.001);起搏器植入率随时间从17.2%(2007-2008年)降至5.4%(2016年)(P=0.02)。作者认为SURD-AVR是传统主动脉瓣置换的安全有效替代方案,并需进一步统计分析以制定高质量循证指南。
要点
- 总体院内死亡率为2.1%,孤立SURD-AVR为1.4%,合并手术为3.5%(P<0.001)。
- 低风险(logistic EuroSCORE<10%)孤立与合并SURD-AVR死亡率分别为0.8%和1.9%,较高风险(≥10%)分别为2.2%和3.7%。
- 起搏器植入率随时间显著下降,从17.2%(2007-2008年)降至5.4%(2016年)(P=0.02)。
核心结论
- SURD-AVR是传统主动脉瓣置换的安全有效替代方案,并伴有良好的临床结局。
- 作者指出,来自回顾性和前瞻性SURD-IR的进一步充分把握度的统计分析将有助于制定SURD-AVR的高质量循证临床指南。
研究设计与样本
- SURD-IR是由18个研究中心组成的国际瓣膜外科研究组(IVSSG)建立的国际注册研究。
- 收集2007至2017年10年间3343例接受SURD-AVR的患者数据。
- 患者平均年龄76.8±6.7岁,36.4%为80岁或以上;平均logistic EuroSCORE为11.3±9.7%。
主要发现
- 孤立SURD-AVR占70.7%(n=2362),采用全胸骨切开(35.3%)或微创入路(64.8%)。
- 总体院内死亡率为2.1%,孤立SURD-AVR为1.4%,合并手术为3.5%(P<0.001)。
- 低风险(logistic EuroSCORE<10%)患者中,孤立与合并SURD-AVR死亡率分别为0.8%和1.9%;较高风险(logistic EuroSCORE≥10%)患者中分别为2.2%和3.7%。
- 术后神经系统并发症包括卒中(2.8%)和短暂性脑缺血发作(1.1%)。
- 需要起搏器的新发房室传导阻滞发生于10.4%的患者;起搏器植入率随时间显著下降,从17.2%(2007-2008年)降至5.4%(2016年)(P=0.02)。
局限性
- 原文在结论中提及需来自回顾性和前瞻性SURD-IR的进一步充分把握度的统计分析,以制定高质量循证临床指南。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: The Sutureless and Rapid-Deployment Aortic Valve Replacement International Registry (SURD-IR) was established by a consortium of 18 research centres-the International Valvular Surgery Study Group (IVSSG)-to overcome limitations of the literature and provide adequately powered evidence on sutureless and rapid-deployment aortic valves replacement (SURD-AVR). METHODS: Data from 3343 patients undergoing SURD-AVR over a 10-year period (2007-2017) were collected in the registry. The mean age of the patients was 76.8 ± 6.7 years, with 36.4% being 80 years or older. The average logistic EuroSCORE was 11.3 ± 9.7%. RESULTS: Isolated SURD-AVR was performed in 70.7% (n = 2362) of patients using full sternotomy (35.3%) or less invasive approaches (64.8%). Overall hospital mortality was 2.1%, being 1.4% in patients who had isolated SURD-AVR and 3.5% in those who had concomitant procedures (P < 0.001). When considering baseline risk profile, mortality rate was 0.8% and 1.9% in low risk (logistic EuroSCORE <10%) isolated SURD-AVR and combined SURD-AVR, respectively, and 2.2% and 3.7% in higher risk patients (logistic EuroSCORE ≥10%). Postoperative neurological complications included stroke (2.8%) and transient ischaemic attack (1.1%). New atrioventricular block requiring pacemaker occurred in 10.4% of the patients. The rate of pacemaker implantation significantly decreased over time [from 17.2% (2007-2008) to 5.4% (2016); P = 0.02]. CONCLUSIONS: Our findings showed that SURD-AVR is a safe and effective alternative to conventional aortic valve replacement and is associated with excellent clinical outcomes. Further adequately powered statistical analyses from the retrospective and prospective SURD-IR will allow for the development of high-quality evidence-based clinical guidelines for SURD-AVR.
引用
- Di Eusanio M, Phan K, Berretta P, et al. Sutureless and Rapid-Deployment Aortic Valve Replacement International Registry (SURD-IR): early results from 3343 patients. Eur J Cardiothorac Surg. 2018. PMID: 29617925. doi:10.1093/ejcts/ezy132
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。